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THE VENTILATORY RESPONSE TO NORMOXIC HYPERCAPNIA IN MALE 
PET-1 KNOCKOUT MICE AND THE INFLUENCE OF FEMALE SEX HORMONES. 
Simon R. A. Best and Matthew R. Hodges (Sponsored by George B. Richerson). 
Department of Neurology, Yale University, School of Medicine, New Haven, CT. 
Purpose: To determine if the deficiency in the hypercapnic ventilatory response as a 
result of 70% loss of serotonergic neurons in male Pet-1 knockout mice and the sparing 
of the female Pet-1 knockout mice can been accounted for and corrected by 
supplementation with estrogen and progesterone. 
Methods: Using whole-body Bow-through plethysmography, 5 male Pet-1 -/- mice and 5 
wild type mice were exposed to room air, 3%, 5%, 7%, and 10% CCE and VE measured. 
All mice were then treated with oral 17P-estradiol (2500 nM) for 48 hours followed by a 
SC injection of progesterone (2 mg/kg). One hour after injection all plethysmography 
studies were repeated. 
Results: Before treatment Pet-1 knockout mice showed a trend towards decreased VE at 
room air, 3%, and 7% CO2, with statistical significance at 5% CO2 (p <0.05), and an 
identical VE only at 10% CO2. Absolute changes in VE after treatment were insignificant; 
the differences in VE between genotypes achieved significance at control, 3%, and 5% 
CO2 (p <0.05) while now VE at 7% and 10% CO2 exposures were identical (p < 0.05). 
Conclusion: The partial recovery of the male Pet-1 knockout phenotype provides 
evidence that the remaining serotonergic neurons can recover some chemoreceptor 
function under the influence of female sex hormones, which in turn may partially explain 
the female Pet-1 knockout phenotype. 
> 
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As a neurotransmitter and a neural system, serotonin has been implicated in a 
wide range of functions and disorders. These include the regulation of sleep, aggression, 
anxiety, and clinical disorders such as depression. Obsessive Compulsive Disorder and 
SIDS. While there is much clinical, pharmaceutical, and physiologic evidence to support 
serotonin’s role in these various functions, little attention has been paid to a unifying 
theory of the serotonin system that could account for these diverse roles. Given its small, 
centrally located nuclei and its extensive connections throughout the CNS it is not 
unreasonable to assume that some primary function could provide the key to its multi¬ 
faceted phenotype. 
Richerson has recently proposed central chemoreception as such a unifying 
function for the serotonin system that takes into account some of primary properties of 
serotonin neurons as well as provides an explanation for its role in these diverse disorders 
(1). 
Chemoreception is the “detection” component of the fundamental homeostatic 
mechanism that is necessary to maintain a body pH between tight physiologic 
boundaries. The primary determinant of pH in humans is carbon dioxide, through its 
stochiometric and enzymatic conversion to bicarbonate and a proton (C02 + H20 -> H+ + 
HCO3). Therefore, candidate chemoreceptors must be able to respond to changes in pH 
by initiating appropriate physiologic defense mechanisms. In the case of pH, the most 
important acute response is the maintenance of Pco2 by the control of lung ventilation. 
The first central chemoreceptors were located by focal acidosis of the cat medulla, 
and an increase in ventilation was in seen on the ventrolateral surface (VLMS) (2). This 
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is the location for the nuclei of multiple types of neurotransmitters, including serotonin, 
whose medullary groups also include the raphe pallidus, raphe magnus, and raphe 
obscurus (3). These serotonergic projections influence cardiovascular control, autonomic 
output, motor control, and pain processing (4-6). They also have a well-described effect 
on breathing. Respiratory nuclei including the nucleus ambiguous, nucleus tractus 
solitarius, phrenic motor nuclei, hypoglossal nuclei, and the preBotzinger complex 
contain serotonergic terminals (7-12). Exogenous application of serotonin analogues 
stimulates respiration in rats and cats (13, 14). This effect is even more pronounced after 
general anesthetic, where respiratory depression or apneusis can be reversed with 
serotonin agonists (12, 15). Electrical stimulation of the raphe pallidus or glutamatergic 
stimulation of the medullary raphe both increase phrenic nerve output (16, 17). As would 
be expected, selective ablation of serotonergic nuclei leads to hypoventilation (18). In 
sum, the primary respiratory effect of serotonin is a stimulation of breathing, thus, if it 
could be shown that these neurons are chemosensitive, the hypothesis that serotonin 
neurons in the VLMS are responsible for pH homeostasis would be an attractive one. 
The lines of evidence that indicate serotonin neurons have the necessary 
“detection” properties required for central chemoreception can be broken down into 
broad categories - (1) in vitro work with single cell culture, (2) specialized anatomic 
considerations, (3) in vivo studies with focal inhibition or destruction of serotonin 




The first clue that serotonergic neurons were involved in chemoreception came 
from rat brain slices, where a subset of neurons in the medullary raphe were found to be 
highly stimulated by changes in PCo2 from 5% to 9% and inhibited by change to a Pco2 of 
3% (19). Another group of neurons showed an opposite response - they were inhibited 
by acidosis and stimulated by alkalosis. Of these subsets, all carbon-dioxide stimulated 
neurons were serotonergic, and none of the carbon-dioxide inhibited were. In cell culture 
experiments it was determined that 75-90% of all serotonin neurons in the medullary 
raphe respond to C02 with an average response of 300% increase in firing frequency (20- 
22). The channel responsible for this sensitivity appears to be a slow 
afterhyperpolarixation calcium-activated cation current (23). 
Anatomic Specialization 
A striking structure-function relation exists for the serotonergic neurons in the 
brainstem. Confocal studies show that serotonergic neurons wrap closely along side the 
main arteries of the brain stem - the basilar artery and its penetrating branches - with 
dendrites that enwrap the vessels and come with half of a micrometer from the arterial 
blood (24). Teleologically, this is the ideal location for central chemoreceptors, as the 
basilar artery contains blood with a Pco2 directly from the lung, reflecting gas exchange 
before it is altered by brain metabolism. This anatomical specialization has not been 




In whole animal studies there is also evidence that serotonergic neurons 
contribute to the hypercapnic response. After hypercapnic exposure, C-fos staining 
increases in CO2 activated neurons - these neurons in the medullary raphe are 
immunoreactive for 5-HT and tryptophan hydroxylase (25, 26). In awake, normally 
behaving cats, a subset of serotonergic neurons increases their firing rate in response to 
exposure to CO2 (27). Two experiments inducing focal acidosis in the medullary raphe - 
by application of acetazolamide or by microdialysis of high CO2 solution - both showed 
an increase in ventilation (28, 29). Similar finding have been achieved in goats, where 
focal acidosis in the medulla increases respiratory output (30, 31). 
Experiments to inhibit or destroy serotonin neurons in the medullary raphe have 
also shown the expected results. When neonatal rats are treated with 5,7-DHT, which 
destroys serotonin neurons, in adulthood they have elevated Pco2 levels at baseline and a 
decreased ventilatory response to CO2U8). Focal lesions of the serotonin system in 
adult rats with 8-OH-DPAT or antibody conjugated to the toxin saporin directed at the 5- 
HT transporter cause a decrease in the ventilatory response to carbon dioxide (32, 33). 
Genetic 
Most recently, the ability to manipulate the serotonin system through genetic 
knockouts eliminates the need for invasive or chemical manipulations (34). Due to the 
high interest in the serotonin system for the study of behavioral and psychiatric systems, 
many variant knockout mice have been developed. One knockout generated is deficient 
in Pet-1, an ETS domain transcription factor critical for the normal development of 
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serotonin neurons. Mice deficient in Pet-1 lack 70% of their serotonin neurons in all 
serotonergic nuclei, with no detectable deficiencies in other neurotransmitter systems or 
brain architecture. The remaining serotonin neurons have dramatically reduced TPH and 
SERT mRNA expression. These deficiencies result in only 10-15% of wild-type 
serotonergic fibers and quantitative levels of serotonin throughout the brain. 
Behaviorally these mice are more aggressive than their wild-type kindred, but have 
normal development, motor function and learning, reproduction, and life expectancy in 
adulthood, although 30% of them die in the first week of life from unknown causes (35). 
If the serotonin system was involved in chemoreception, Pet-1 knockout mice might be 
expected to have a deficient response to hypercapnia if peripheral chemoreceptors and the 
remaining serotonin neurons were unable to compensate sufficiently. 
Indeed, recent studies with normoxic hypercapnic challenges have shown that 
Pet-1 knockout mice do not have a normal response [Fig 1 (a)] (36). This deficit appears 
to be mild, but when the results are sorted by the sex of the mice, a striking picture 
emerges, where the male mice have a clearly deficient response [Figure 1 (b)] and the 
female response is essentially normal [Figure 1 (c)]. This intriguing result suggests that 


















RA 0.01 0.03 0.05 0.07 0.09 0.11 
FiCOz 
Figure 1 (a) 
The most obvious source of sex differences is the influence of the female sex 
hormones estrogen and progesterone, especially since there is a well documented 
stimulatory effect of female sex hormones upon breathing, primarily progesterone, in 







































re 1 (b) 








3% 5% 7% 10% 
FiC02 
Figure 1 (c) 

12 
Sex Hormones and Respiration 
Very early evidence for the effect of sex hormones on respiration was the 
observation that pregnant women have decreased alveolar and arterial Pco2 (39, 40). The 
same effect was also seen during the luteal of the menstrual cycle (41) and these cyclic 
fluctuations disappeared after menopause (42). These observations were then correlated 
with progesterone (43), and further in pregnant women as the log of serum progesterone 
(44) . 
Progesterone was then shown to be a respiratory stimulant in normal, healthy men 
(45) in multiple physiologic states including exercise and sleep (46). Clearly men do not 
have the progesterone influence of pregnancy, but the one instance of a hyper 
progesterone and estrogen state in males is cirrhosis of the liver. Cirrhotics have long 
been known to have a baseline respiratory alkalosis, and when a group of patients with 
liver disease were divided into those with severe or mild hyperventilation those with 
greater hyperventilation had higher serum levels of estrogen and progesterone (47). It is 
interesting to note that the levels of progesterone that apparently stimulated breathing in 
cirrhotics were two orders of magnitude less than that in pregnant woman, which may 
reflect different sensitivities to the effect of sex hormones. 
These hormones may have an effect on common respiratory diseases in humans, 
specifically Obstructive Sleep Apnea (OSA), which has a strong male predominance 
(48). Women are protected until menopause (49) - 11% of premenopausal women 
suffered from nocturnal desaturation, hypopneas or apneas during sleep in one study, 
while 60% of postmenopausal women had the same symptoms (50). There is also 
evidence that women taking hormone replacement therapies were protected (51). 
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Synthetic progestins (most commonly Medroxyprogesterone [MPA]) were therefore used 
as a treatment for OSA, and some studies showed improvements in blood gas levels, 
sleepiness, and apneic events in males (52-54). Since estrogen increases progesterone 
receptors (55) in females a combination hormone replacement therapy incorporating 
estrogen reduced sleep associated breathing disorders (56-58). 
The ventilatory effects of estrogen and progesterone have also been duplicated in 
other animal systems. Guinea pigs (59), Jersey cows (60), rabbits (61), and goats (62) 
hyperventilate when they are pregnant. However, chronic progesterone to male rabbits 
and goats did not increase ventilation (63). Female rats do not have a ventilatory 
response to MPA alone, although when MPA is combined with estrogen the number of 
progesterone receptors increases and ventilation increases (64). This finding was 
duplicated in male rats, where only the combination of estrogen and a progesterone 
analog had an effect on arterial blood gas parameters (65). Work in cats showed the 
same requirement for estrogen and progesterone and further refined the model by 
blocking the response with an estrogen receptor antagonist, progesterone receptor 
antagonist, and inhibitors of protein and RNA synthesis (66). Therefore it was concluded 
that the ventilatory response is dependent upon both receptors as well as gene expression, 
consistent with the known mechanism of steroid receptor activation. 
There are a few mechanisms possible for the ventilatory changes seen as a result 
of female sex hormones. The most attractive for the purposes of the current study is that 
estrogen and progesterone alter the hypercapnic ventilatory response (HCVR) ie) they 
influence central chemoreception. In men, administration of progesterone stimulated 
ventilation and also increased the HCVR versus placebo without changing the hypoxic 
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ventilatory response (45). In women, the change in ventilation in the luteal phase of the 
cycle was shown to be due to a difference in the carbon dioxide sensitivity (67). In post¬ 
menopausal women administration of estrogen and progesterone combined with mild 
exercise (to increase metabolic rate) caused an increase in ventilation that mimicked the 
effects of pregnancy. The authors showed that both progesterone alone and the 
combination of estrogen and progesterone caused a significant change in the HCVR (68). 
Finally, in pregnant women themselves, a challenge with hyperoxic hypercapnia showed 
a significant difference in both the HCVR and the threshold at which this response was 
activated (69). 
Certainly other mechanisms besides a change in the HCVR could be involved. 
Both male and female rats express ERa, ER[), and androgen receptors in the hypoglossal 
and phrenic motoneurons and nuclei, although no progesterone binding was seen (70). 
Sex hormones could be functioning as amplifiers of the normal HCVR simply by driving 
stronger motor output. They could also change the basic respiratory rhythm, however, 
there is no evidence that respiratory pattern generation generated by the pre-Botzinger 
complex is altered by sex hormones (38). 
Female sex hormones clearly have an influence on respiratory parameters across a 
wide variety of species, and perhaps even a specific effect on the hypercapnic ventilatory 
response. Therefore we hypothesized that supplementation of the male Pet-1 knock-out 
mice with physiologic levels of estrogen and progesterone would partially or completely 
restore the deficiency in their normoxic hypercapnic ventilatory response. 
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Statement of Purpose 
The specific aims of this study were therefore: 
1) To confirm the deficient ventilatory response of male Pet-1 knockout mice in 
response to normoxic hypercapnic challenges through whole-body 
plethysmography 
2) Supplement the same male Pet-1 knockout mice with estrogen and progesterone 
and quantify the change, if any, in their hypercapnic ventilatory response as a 
result of hormone treatment 
in order to: 
Prove or disprove the hypothesis that the female sex hormones estrogen and 
progesterone are responsible for the sex differences in the hypercapnic ventilatory 




The protocol followed for these experiments was based upon a modified 
experimental design for previously published data (36) and approved for use by the Yale 
Animal Care and Use Committee. 
10 male PET-1 mice (5 PET-1 -/-; 5 PET-1 +/+) generated from a breeder colony 
generously donated by the Deneris lab at Case Western were utilized for these 
experiments. All animals were kept in the Yale Animal Care Facilities and provided 
standard care - 12 hour diurnal cycles with freely available food and water. 
Plethysmography 
All plethysmography experiments were carried out in the following manner with 
the investigator blind to the mouse genotype. The mouse to be studied was weighed prior 
to experimentation and the ambient barometric pressure recorded. The mouse was then 
placed inside the airtight plethysmography chamber [Figure 2 (a)] which was connected 
to a gas manifold, a vacuum with a flow regulator, and a pressure transducer. When 
sealed, the plethysmography chamber and pressure transducer records a change in 
pressure that varies directly with the animal’s breathing as the inhaled gas is warmed and 
humidified in the lungs (71). A custom designed Matlab 7.0.2 program then converted 
the output voltage of the transducer into a linear trace of the pressure in the chamber, 
while simultaneously recording the voltage at a sampling rate of 100 Hz. The pressure in 
the box could therefore be monitored to insure an accurate ventilatory signal and prevent 
a buildup of negative or positive pressure in the closed system. An extra chamber with a 
' 
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needle valve connected to the main plethysmography chamber provided an additional 
pressure release point while buffering the chamber against sudden changes in 
atmospheric pressure (such as a door opening in the laboratory). This design is consistent 
with standard procedures for plethysmography experiments. 
Figure 2 (a) 
When placed in the plethysmography chamber each mouse was then exposed to a 
set protocol of gases [Figure 2 (b)l. Each exposure was set at ten minutes to allow the 
animal’s breathing to stabilize while minimizing fatigue. Ten minutes at room air (21% 
O2, balance Nitrogen) was followed by ten minute exposures to C02 mixes containing 
3%, 5%, 7%, and 10% C02 respectively with 21% 02 and balance Nitrogen. Every C02 
exposure was alternated with ten minutes of room air exposure to allow for multiple 
sampling of the baseline ventilation and prevent respiratory fatigue secondary to 
prolonged hypercapnic exposure. Connected in series with the plethysmography 
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chamber was an O2 and CO2 analyzer which could verify the achievement of a stable CO2 
exposure level. The mouse was continually monitored throughout the experiment to 
maintain a state of quiet wakefulness, as sleep has an effect on the ventilatory response to 
hypercapnia (72, 73). Ten second time periods of quiet breathing were noted throughout 
the experiment to ensure usable data and marked for further analysis. At the end of each 
set of plethysmography experiment a lcc syringe was used to repeatedly inject 0.1 cc of 
air into the chamber with and without the mouse. This established a known volume to 
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In order to test the hypothesis that the deficiency seen in the ventilatory response 
of the male mice was a result of the relative lack of female sex hormones, the male mice 
were supplemented with estrogen and progesterone in the following manner. Each 
mouse served as its own control for these experiments, and was therefore studied in the 
plethysmography chamber as outlined above on Day 0, immediately prior to commencing 
hormone supplementation. The goal of hormone supplementation was to recapitulate as 
closely as possible the normal serum levels of both female sex hormones in the male 
mice, rather than administer a supra-physiologic dose. Normal female mice in their 
normal estrus cycle have a serum estrogen between 10 and 30 pg/ml (74), and serum 
progesterone between 10-60 ng/ml (75). 
The adult male mice were treated with estrogen through their drinking water, as 
oral estrogen has good bioavailability. 17(3-estradiol was dissolved at a 20 mM 
concentration in 95% ethyl alcohol (EtOH) and then diluted to a concentration of 2,500 
nM in the standard chlorinated drinking water of the mice. Their daily water intake was 
then substituted with the estrogen drinking water. Preliminary supplementation in non- 
experimental mice had already been undertaken to show that Pet-1 mice drank the 
supplemented water and achieved their daily intake needs without dehydration. Estrogen 
drinking water at 2,500 nM dose has been shown to correspond to an estrogen serum 
level of 38 pg/ml - at the high range of estrogen throughout the normal mouse estrus 
cycle (76). Each experimental mouse had access to the estrogen drinking water for 48 
hours, immediately following their control protocol in the plethysmography chamber. 
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Stable plasma levels of estrogen would be expected within six hours of oral 
administration, well within the exposure duration for this experiment (77). 
As progesterone is extensively metabolized by the liver on first pass and therefore 
has poor oral bioavailablity it is most commonly administered by intramuscular injection 
or subcutaneous capsules. Although progesterone has a half-life in circulation of only 5 
minutes, suspension in sterile sesame oil allows for a depo-like effect with slowly 
declining serum levels after a single injection or implantation (78, 79). Experiments in 
humans have shown that injection at a dose of 1.5 mg/kg achieves a serum level between 
5 and 50 ng/ml over 48 hours (78), slightly lower than the normal level in mice. The 
male mice therefore received a subcutaneous injection of 2 mg/kg of progesterone 
suspended in 0.1 mL of sterile sesame oil one hour before the plethysmography 
experiment. 
It was noted during the course of these experiments that following the injection 
some sesame oil would be expressed back out of the injection site, usually following 
vigorous motor activity. While this would have reduced the total progesterone dose 
received by the mouse, the pharmacokinetics of progesterone is such that the dose 
injected has less of an impact on peak plasma levels than on the duration of the elevation. 
In humans, a dose one quarter of the dose utilized in these experiments achieves similar 
peak plasma levels of progesterone, however, the duration of the elevation is shortened 
from 24 hours to 12 hours (78). Qualitative assessment after depositing 0.1 mL of 
sesame oil directly onto the skin of a mouse suggested that much greater than 50% of the 
injected dose remained subcutaneous throughout the experiment. As the experiments 
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lasted for approximately 3 hours post-injection, even 50% of the in jected dose would 
produce target plasma levels for many hours longer than required. 
Data Analysis 
The voltage vs. time data was recorded for each experiment in MatLab file 
format, according to the previously described protocol. Another custom-designed 
MatLab 7.0.2 was used to access this fde and display it in plotted form, where the data 
could be explored for ten second segments of quiet breathing, without mouse movement, 
sniffing, or sighs. Breaths during the segment were identified by the peaks and troughs 
of the voltage, and the interspike interval and amplitude was averaged across all breaths 
in the segment. This procedure was repeated across all CCL exposure levels with the goal 
of finding at least six ten second segments of useable data during each gas exposure. The 
mean interbreath interval and amplitude along with standard deviations were then 
calculated for each gas exposure by averaging the values from the ten second segments. 
The final room air interbreath interval and amplitude was obtained by an average of all 
five ten minute exposures to minimize the effect of escalating CCL on baseline 
ventilation. The volume calibration performed with the mouse in the chamber was then 
used to assist calculations of the absolute tidal volumes from the average voltage 
deflection per breath in the following manner. 
Since the pressure exerted by any gas varies with its temperature and partial 
pressure of fLO, the air warmed and humidified by the lungs expands, and increases the 
pressure in the sealed chamber upon inhalation. The chamber temperature (Tc) and 
relative humidity (both measured parameters) are used to calculate the partial pressure of 
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water in the chamber (PcH2o)- The animal’s pulmonary temperature is assumed to be 
equal to the animal’s body temperature (Ta), with the relative humidity of the inspired air 
equal to the saturation humidity at that temperature. Because the animal’s temperature 
was not directly measured in these experiments, it was assumed to be 37° C for all 
animals and the water pressure of pulmonary air calculated (PaH2o)- The known 
calibration volume (Veal) injected into the chamber that causes a known pressure change 
(Peal) was used to scale the following formula derived from the ideal gas law, where Pb 
is the ambient barometric pressure and where A equals the voltage deflection of the 
animal’s breath (80): 
VT = A (Veal / Peal) [Ta(Pb - PcH2o)l / [[Ta(Pb - Pch2o)] - [Tc(Pb - Pan2o)]J 
As the frequency of respiration is easily generated from the interbreath interval 
(Frequency = 1 / IB Interval), absolute ventilation (VE) can be calculated by taking the 
frequency multiplied by tidal volume. 
VE (mL / minute) = Frequency * Vj 
Since the absolute tidal volume (mL) depends on the size of the mouse and the 
relative size of its lungs, pooling data from all mice require that both Vj and VE be 
scaled. A surrogate and more easily measured variable for total lung capacity is the 
weight of the mouse. VT and VE are therefore reported as adjusted for mass - VT (mL / g) 
and VE (mL / minute/ g). 
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For every mouse a respiratory frequency, VT, and Ve were calculated for each ten 
minute gas exposure (Room Air, 3%, 5%, 7%, and 10% C02). As explained above, in 
order to minimize variability in the control measurement as a result of escalating C02, the 
final control frequency, VT, and VE were obtained by an average of all five control 
exposures. These results were then pooled and sorted by genotype with statistical 
significance determined by the Paired Student’s T-test. 
Results 
Consistent with the previous experiments on Pet-1 mice, a deficiency in their 
ventilatory response to normoxic hypercapnia was seen across multiple C02 levels. Seen 
side-by-side, the ventilatory tracing of a Pet-1 knockout mouse can be readily 
distinguished from a wild-type mouse across multiple C02 exposures [Figure 3]. 
Before hormone treatment each genotype’s ventilatory response was characterized 
according to tidal volume, frequency, and ventilation (VE) [Figure 4 (a), (b), (c)]. Little 
difference was seen in tidal volume between the wildtype versus knockout - at Room Air 
(1.54 ± 0.08 vs. 1.37 ± 0.11 ml/g), 3% C02 (2.00 ± 0.18 vs. 1.72 ± 0.13 ml/g), 5% C02 
(2.18 ±0.16 vs. 1.83 ±0.17 ml/g), 7% C02 (2.31 ± 0.16 vs. 2.13 ± 0.10 ml/g), and 10% 
C02 (2.48 ± 0.17 vs. 2.49 ± 0.12 ml/g) these differences were not statistically significant 
(p >0.05 for all data points). 
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Tidal Volume Pre-treatment 
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Figure 4 (a) 
A different result was seen for frequency. Across most of the range of CO2 
exposure there was a statistically significant difference between the wildtype and 
knockout mice. At 3% CO2 (282 ± 10 vs. 242 ± 8 breaths/minute; p <0.05), 5% (301 ± 
14 vs. 260 ± 8 breaths/minute; p <0.05), and 7% (315 ± 14 vs. 270 ± 11 breaths/minute; p 
= <0.05) the difference in frequency was statistically significant. As would be expected 
if the baseline ventilation was unaffected, the control respiratory frequency was not 
statistically significant between the two groups (179 ± 10 vs. 167 ±10 breaths/minute; p 
= NS). Interestingly, the breathing frequency was similar between the two groups at 10% 
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Figure 4 (b) 
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Figure 4 (c) 
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The difference in respiratory frequency therefore accounts for most of the 
difference in overall ventilation between the two groups. There was a trend towards 
lower overall ventilation under control conditions in the knockouts (028 ± 0.02 vs. 0.23 ± 
0.02 ml/min/g; NS). The same trend was noted across all gas exposures up to 10% CCF 
although it achieved statistical significance only at 5% CO?: 3% CO2 (0.57 ± 0.07 vs. 
0.42 ± 0.04 ml/min/g; NS), 5% C02 (0.66 ± 0.06 vs. 0.48 ± 0.04 ml/min/g; p <0.05), and 
7% C02 (0.73 ± 0.06 vs. 0.58 ± 0.05 ml/min/g; NS). At 10% CO2, the knockout’s 
ventilatory response has clearly recovered to equal that of the wildtype (0.76 ± 0.06 vs. 
0.72 ± 0.04 ml/min/g; NS). This result could suggest that mechanisms other than the 
serotonin system could assist in the ventilatory response under extreme duress and will be 
more fully discussed later. 
Graphing the results as percent change from the control exposure gives a different 
perspective on these results [Figure 4 (d)]. The hypercapnic ventilatory response 
(HCVR) is usually determined from the slope of the C02 response across multiple C02 
levels (AVf/AFiC02). As seen from the % Response curve for the wildtype and knockout 
mice each genotype has a change in ventilation from their baseline, although as discussed 
previously, the absolute ventilation across multiple carbon dioxide levels trends lower at 
all hypercapnic exposures other than 10% C02. 
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Figure 4 (d) 
Hormone Therapy 
After acute treatment with hormone therapy the same ventilatory parameters were 
measured again [Figure 5 (a), (b), (c)]. 
As seen before hormone therapy, there was no difference between the wild type 
and knockout groups in tidal volume, nor were the tidal volumes increased consistently as 
a result of the hormones. At all exposures there was not a statistical difference between 
the groups: control (1.48 ± 0.05 vs. 1.35 ± 0.07 ml/g; NS), 3% C02 (1.88 ± 0.07 vs. 1.62 
±0.09 ml/g; NS), 5% C02 (1.95 ±0.09 vs. 1.95 ±0.1 ml/g), 7% C02 (2.07 ± 0.12 vs. 
2.20 ± 0.12 ml/g), and 10% C02 (2.29 ± 0.1 vs. 2.50 ± 0.15 ml/g). 
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Tidal Volume Post-treatment 
Figure 5(a) 
Similar to the results seen before hormone therapy, the ventilatory frequency was 
the respiratory parameter that showed the most difference between the two groups. At 
room air (195 ± 8 vs. 154 ± 11 breaths/minute; p <0.05) and all carbon dioxide exposures 
up to 7% CO2 there was a significant difference between the two genotypes: 3% C02 
(294 ± 7 vs. 225 ± 10 breaths/minute; p <0.001), 5% C02 (300 ± 10 vs. 248 ± 6 
breaths/minute; p <0.005). At 7% C02 (308 ±11 vs. 282 ± 13 breaths/minute; NS) and 
10% C02 (307 ± 9 vs. 278 ± 13 breaths/minute; NS) there was no statistical significance 
between the groups. Therefore, hormone therapy with estrogen and progesterone did not 
alter the basic characteristics of the differences in hypercapnic ventilatory response 





























Total ventilation continued to be reduced in the knockout mice at control and 
lower C02 levels even after treatment with estrogen and progesterone, although the 
ventilation recovery seen in the knockout mice at the highest CO2 exposure was now 
obvious at both 7% and 10% C02. The difference between the groups was statistically 
different at room air (0.29 ± 0.02 vs. 0.21 ± 0.01 ml/min/g; p <0.005), 3% C02 (0.55 ± 
0.03 vs. 0.37 ± 0.02 ml/min/g; p <0.0005), and 5% C02 (0.58 ± 0.03 vs. 0.48 ± 0.02 
ml/min/g; p <0.05). After treatment total ventilation at both 7% CO2 (0.64 ± 0.06 vs. 
0.62 ± 0.06; NS) and 10% CO2 (0.71 ± 0.05 vs. 0.70 ± 0.07 ml/min/g; NS) was not 
statistically different. This result could suggest that the mechanism that responds to 
higher levels of hypercapnic stress is hormone sensitive. 
This finding is emphasized by a plot of the ventilatory response compared as a 
percent to the baseline room air breathing [Figure 5 (d)]. Before treatment the knockout 
group had a similar slope to the wildtype, but under the influence of female hormones it 
shows a more robust response, especially at the higher CO2 levels. Flowever, this trend 
was not statistically significant; 7% CO2 (227 ± 27 vs. 305 ± 33 % response; NS) and 
10% C02 (250 ± 25 vs. 344 ± 41 % response; NS). 
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% Response Post-treatment 
Figure 5(d) 
When comparing the absolute ventilation with and without hormones there are 
little differences between the wildtype or knockout groups to suggest that absolute 
ventilation changed as a result of hormone treatment [Figure 5 (e)]. At room air and 
across all CCF exposures there was no significant change in VE in the wildtype group: 
room air (0.28 ± 0.02 vs. 0.29 ± 0.02 ml/min/g), 3% CCF (0.57 ± 0.07 vs. 0.55 ± 0.03 
ml/min/g), 5% CO? (0.66 ± 0.06 vs. 0.58 ± 0.03 ml/min/g), 7% CCF (0.73 ± 0.06 vs. 0.64 
± 0.06 ml/min/g), and 10% CCF (0.76 ± 0.06 vs. 0.71 ± 0.05 ml/min/g). Therefore it does 
not appear that this level of acute supplementation with female hormones stimulated 
breathing in the wildtype mice. 
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Similarly there was no difference in absolute ventilation in the knockout group as 
a result of hormone treatment when directly compared to the pretreatment ventilation: 
room air (0.23 ± 0.02 vs. 0.21 ± 0.01 ml/min/g), 3% C02 (0.42 ± 0.04 vs. 0.37 ± 0.02 
ml/min/g), 5% C02 (0.48 ± 0.05 vs. 0.48 ± 0.02 ml/min/g), 7% CO, (0.58 ± 0.05 vs. 0.62 
± 0.06 ml/min/g), and 10% C02 (0.72 ± 0.04 vs. 0.70 ± 0.07 ml/min/g). 
VE - All groups 
Figure 5 (e) 
The higher percentile response seen after hormone treatment in the knockout 
group is due to a combination of factors - a slight decrease in the room air ventilation for 
the knockout group versus a slight increase the wildtype, along with a small decrease in 
the overall response of the wildtype that magnifies the effect of an identical response in 
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the knockout group. Therefore it can be concluded that supplementation with female sex 
hormones did not significantly impact the absolute ventilation of either the wildtype or 
knockout Pet-1 mice, but there is evidence that it changed the relative response between 
the groups at higher CCf exposures. 
Discussion 
The goals of this study were to 1) confirm and further define the deficiencies of 
the Pet-1 male’s response to normoxic hypercapnia and to 2) determine if this deficiency 
could be accounted for and corrected by physiologic supplementation with female sex 
hormones. 
In a confirmation of previously obtained results, the Pet-1 knockout mice showed 
a statistically significant deficiency in their total ventilation, mainly at lower hypercapnic 
exposures. The trend seen pre-treatment did not achieve statistical significance except at 
5% CO2 most likely because of the small sample size. However, as their room air 
ventilation was also depressed relative to the wildtype mice, their ventilatory response 
seen as a percentage of baseline was not different than the respiratory response of the 
wildtype. This raises the important question of the most accurate determinant of the 
hypercapnic ventilatory response. The HCVR is most commonly expressed as the slope 
of Ve, which takes into account both the baseline ventilation and the hypercapnic 




Despite this result, there is a clear phenotype for the male Pet-1 knockout mice 
compared to their wildtype kin. Their total ventilation is reduced both at room air and for 
all hypercapnic exposures except 10% CCX As is readily evident from the VE graph, the 
decrease from the wildtype ventilation is not equivalent across all exposures, as might be 
expected if the loss of serotonergic neurons interfered with the fundamental mechanisms 
of breathing such as respiratory pattern generation, phrenic discharge, or diaphragmatic 
function. At room air, the knockout's Ve is 82% that of wildtype, 74%, 73%, and 79% at 
3%, 5% and 7% CO2 respectively and finally 95% at 10% CCf. These variable results 
argue strongly that the disruption of the serotonin system in the Pet-1 mice does have an 
effect on the hypercapnic ventilatory response, but also that this effect is not uniform 
across the possible range of hypercapnic stressors. It could be concluded therefore, that 
the serotonin system plays an important role in maintaining baseline ventilation and the 
response to CO2 at lower exposure levels, and that a secondary hypercapnic response 
independent of the serotonin system can assist in driving ventilation at higher carbon 
dioxide stresses. 
There is a precedent for this result in other knockout genotypes also deficient in 
the serotonin system. Mice deficient in Lmxlb (a transcription factor necessary for 
neuronal development (81) driven by the Pet-1 promoter are more severely deficient in 
serotonin neurons than the Pet-1 knockout mice. These mice lack up to 99% of their 
serotonergic neurons in all serotonin nuclei. When tested in whole body 
plethysmography in a fashion similar to the Pet-1 mice, although using hyperoxic 
hypercapnia to disable peripheral chemoreceptors rather than normoxic hypercapnia, 
these mice show a more profound deficiency in their HCVR across a range of CCP 
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similar to the results reported here [Figure 6], The slope of Vg is linear (representing the 
HCVR) until 10% CCT, where a more robust ventilatory response is seen. This biphasic 
response suggests that the serotonin system is functioning as a central chemoreceptor 
responsible for driving a ventilatory response to CCF, but also that secondary neural 
systems can “rescue” the response under severe enough acidosis. 
Lmxlb Knockout 
RA 0.01 0.03 0.05 0 07 0.09 0.11 
FiC02 
Figure 6 
Seen in this context, the results from the current study support the theory of the 
serotonin system as a central chemoreceptor, albeit one whose effect is not constant 
across the entire range of hypercapnic challenges. However, the 70% loss of serotonin 
neurons appears to have only resulted in a -25% loss of ventilatory response. What 
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could account for this difference if the hypothesis that serotonin contributes to the HCVR 
is accepted? 
First, the experiment performed here took place under normoxic conditions. As 
has been well-described, peripheral chemoreceptors located in the carotid body provide 
the majority of the ventilatory response to hypoxia, but they also modulate the response 
to hypercapnia through changes in the parasympathetic or sympathetic systems and also 
respond directly to high CCF challenges (82, 83). Performing these experiments under 
hyperoxic conditions would decrease the influence of the peripheral chemoreceptors and 
might therefore unmask more of the Pet-1 knockout phenotype. 
Second, there is no reason to presuppose that the phenotypic response should be 
linear ie) a 70% loss of serotonergic neurons would lead to a 70% reduction in the 
hypercapnic response. In fact, there are good reasons to suppose otherwise. 1) Although 
a 70% reduction in the number of serotonin neurons is quantitatively impressive, this 
does not address the capacity of the remaining 30%. These remaining neurons could be 
simply sufficient on their own to drive a ventilatory response or they could upregulate 
key transporters or enzymes as a compensatory response. Work with other 
neurotransmitter systems has shown that a surprisingly small number of remaining 
neurons can support essential functions. For example, in patients with unilateral 
Parkinson’s Disease, imaging of the unaffected contralateral side shows a loss of up to 
40% of the dopamine neurons (84). 2) Chemosensitivity is an extremely important 
homeostatic mechanism, and in the absence of a normal serotonin system it is possible 
that other neurotransmitter systems that normally have a minor role in chemosensitivity 
could be recruited for this function. Other candidate systems could include neurons of 
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the locus coeruleus (85-87), retrotrapeziod nucleus (RTN) (88, 89) or the nucleus tractus 
solitarius (NTS) (90, 91). 3) There are also inherent difficulties in interpreting the results 
of knockout mice. Soon after the development of homologous recombination to 
eliminate target genes, many knockout mice were generated that had surprisingly normal 
phenotypes given the thought-to-be essential nature of the target gene (92). In many 
cases this phenotypic normality has been attributed to gene redundancy, recruitment of 
alternative systems for compensation, or the superfluous nature of the target gene. This 
has led to the current popularity of “conditional knockouts”, where the temporal control 
over a gene allows for normal protein function during development, thus preventing 
accessory or redundant systems from compensating when the protein is removed in adult 
life (93). While the Pet-1 mice do exhibit a clear neuropathologic phenotype, it is not 
clear what the effect of a reduction of serotonin neurons during fetal and early 
development has on normal brain function. 
It should be noted that every one of these caveats argues for a normalization of 
phenotype, and therefore the -25% reduction seen in ventilation and its differential 
relationship to hypercapnia is an extremely strong argument for the role of serotonin 
neurons in normal central chemosensitivity. 
Sex Hormones and Chemosensitivity 
The second goal of these experiments was to address the ability of female sex 
hormones to account for the differences seen between male and female Pet-1 knockout 
mice. A combination of estrogen and progesterone was used based upon work in rats 
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discussed earlier that showed the need for both hormones to increase ventilation in males 
and females. 
A comparison of pre and post-hormone treatment total ventilation (VE) provides 
no evidence that the baseline ventilation of either the wildtype or the Pet-1 knockout 
group was affected by hormone therapy. This result is surprising given the extensive 
evidence that progesterone is a respiratory stimulant. Unfortunately, as there is no 
consensus about dosing or administration of these hormones, many of the experiments 
that show the stimulatory effects of progesterone use supra-physiologic doses. 
In the current study progesterone was dosed at 2 mg/kg in an attempt to 
recapitulate normal female hormonal levels. In comparison, stimulation of ventilation in 
female rats was achieved with MPA dosed at 8 mg/kg x 4 days (64). In order to stimulate 
ventilation in male rats, they were fed TZP4238 (a progesterone analog with a potency 
300-400 times that of progesterone) at 4 mg/kg, even though some respiratory effects 
were seen at 0.4 mg/kg (65). For the purposes of the current study, proving the ability of 
supra-physiologic progesterone to stimulate ventilation in Pet-1 mice would have had no 
relevance on the experimental question. Clearly, if the female Pet-1 knockout mice are 
protected by circulating sex hormones these hormones can provide adequate protection 
within physiologic ranges. 
While the baseline ventilation was not affected, the sex hormones did appear to 
influence the ventilatory response at higher CCA exposures. The basic pattern seen pre¬ 
treatment, where ventilation at Room Air and lower COi exposures was diminished, was 
retained only until 5% CCF - after hormone treatment the knockout’s VE was 72%, 67%, 
and 83% that of wildtype at Room Air, 3%, and 5% respectively. The ventilatory 
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recovery was 97% and 99% at 7% and 10% CO2, although the caveats discussed earlier 
still apply - this difference was due to a small size in the absolute ventilation of the 
knockout along with a small decrease in the VE of the wildtype. 
If this recovery is real and due to the hormone exposure, there are two possible 
interpretations of this result: 1) The deficiency in the HCVR seen in the knockout mice 
as a result of the loss of serotonin neurons can be influenced by female sex hormones, or 
2) secondary chemoreceptive mechanisms are influenced by female sex hormones and 
therefore “kick in” at earlier hypercapnic stresses. These are by no means mutually 
exclusive, and teleologically the rescue at 7% CO2 could be explained either way. If the 
remaining serotonergic neurons were enhanced by female sex hormones, this effect 
would surely be seen when the neurons were receiving maximum extrinsic stimulation ie) 
at the highest COo exposure. Similarly, redundant chemoreceptive neurons could be 
recruited at lower and lower CO2 thresholds if they were responsive to sex hormones. 
Neither of these options can be ruled in or out at this point, so it can therefore be 
cautiously concluded that there is evidence that supplementation with physiologic levels 
of female hormones can restore some of the ventilatory deficiencies seen as a result of the 
loss of serotonin neurons. 
Now that there is some experimental evidence that estrogen and progesterone can 
manipulate the phenotype caused by reduced serotonergic neurons it is reasonable to ask 
if there are other lines of evidence to support this interaction. Clear connections between 
the serotonergic system and sex hormones could tip the explanatory balance towards 
serotonergic neurons and away from the unknown redundant chemoreceptors. 
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Due in large part to the role of the serotonin system in psychiatric disease - 
mainly depression and anxiety, both of which affect females more than males (94) - the 
intersection between the serotonin system and sex hormones is an active area of research 
(95). 
Estrogen and progesterone act through nuclear receptors - estrogen receptors in 
two major isoforms ERa and ER(3 (96) and progesterone isoforms PR-A and PR-B (97). 
In most species studied thus far including monkey, guinea pig, and mice, ER(3 is the form 
that is expressed most highly in the dorsal raphe. In mice, both isoforms colocalize with 
serotonin neurons (98), although ER(3 has a higher rate of colocalization in the dorsal 
raphe (90%) than ERa (23%) in male mice (99). Progesterone receptors in the 
serotonergic neurons are upregulated by ER|3 activation in both mice and monkeys and 
downregulated by progesterone (100, 101). 
What is known about the effects on the serotonin system of activating these 
receptors? One key measure of serotonin activity is the level of TPH, which is the rate- 
limiting enzyme in the production of serotonin. When activated by estrogen, serotonin 
neurons upregulate TPH mRNA in both guinea pigs (102) and macaques (103), and the 
same effect has recently been shown in mice to be mediated through ERfl (104). Whether 
this increase in mRNA results in increased TPH protein is not yet known in mice, but has 
been shown to be the case in guinea pigs and macaques (102, 103). 
Another regulatory target of estrogen and progesterone could be SERT, the 
serotonin reuptake transporter. Treatment with estrogen increased SERT mRNA in the 
dorsal raphe of rats (105) although the opposite effect (decreased SERT mRNA) was 
seen in macaques (106). The physiologic effect of transport regulation is unclear 
V 
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however, since serotonin binding and uptake can be increased even the face of decreased 
SERT mRNA (106). In mice, a low estrogen state led to a reduced density of SERT in 
the hippocampus but a paradoxical increase in SERT activity (107). Other possible 
targets for protein regulation like the 5HT1A autoreceptor (108) or MAO-A (109) show 
responses to various combinations of estrogen and progesterone. 
It can therefore be concluded that serotonin neurons have the basic properties 
necessary to respond to female sex hormones - they express the appropriate receptors and 
have the ability to regulate both mRNA and protein in response to these signals. It is 
equally clear however, that invoking sex hormones to account for the difference in the 
Pet-1 knockout mice requires that sex hormones be able to modulate serotonergic neural 
responses. 
Accordingly, a wide range of functions in which serotonin is implicated have 
been shown to be modulated by female sex hormones (110). The most basic of these is a 
difference in the tonic activity of dorsal raphe serotonin neurons between the sexes. In 
male rats, serotonergic neurons were found to have an average firing rate 41% higher 
than normal and ovariectomized females that was not correlated with circulating levels of 
progesterone and estrogen. During pregnancy, the basal firing rate of the females 
increased up to 136%, and this rise and subsequent fall late in pregnancy was closely 
reflected in the circulating progesterone level (111). Further work by the same group 
established that these differences were due to a partial desensitization of the 5-HT1A 
receptors during pregnancy (112). Stimulation of the basal firing rate was achieved with 
intra-cerebral ventricular DHEA, progesterone, and its metabolites in the females (113), 
but these effects were not seen in males. Instead, the baseline rate in both males and 
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females was modulated by testosterone as well as with estrogen (which lies downstream 
from testosterone in metabolism) (114). 
It would be imprudent to attempt to summarize all other actions of female sex 
hormones on the serotonin system here, suffice it to say that their ability to act on it is 
well-established (110). 
The specific function in question here is the role of sex hormones on the serotonin 
system as it pertains to breathing. There is not much experimental evidence in this area, 
apart from the current study, the only work to address this question measured serotonin 
levels in respiratory nuclei in male and female rats throughout their estrus cycle (38). 
Females were found to have significantly higher levels of serotonin in the hypoglossal 
nucleus than the males, but equal levels in the phrenic nucleus. The serotonin levels in 
the different nuclei changed throughout the estrus cycle, with interesting results. In the 
hypoglossal nucleus, the changes in serotonin levels closely mirror plasma estrogen, 
while in the phrenic nucleus serotonin levels mirrored serum progesterone. These results 
are consistent with the current study, as downstream targets would be expected to show 
increased level of serotonin as the HCVR is influenced by hormonal status. 
Given the enormous amount of evidence that links the serotonergic system with 
female sex hormones any evidence that the knockout phenotype of the Pet-1 male mice is 
altered by estrogen and progesterone must be taken seriously. The question remains 
however, if it accepted that estrogen and progesterone restored some of the remaining 
serotonergic function, why did they not restore all of the difference between the male and 
female Pet-1 knockout mice? 
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It is certainly possible that a higher dose of estrogen and progesterone could have 
shown a larger impact on the ventilatory response, but this would not have addressed the 
phenotypic difference between the sexes. Ovariectomy in the female mice would also 
have addressed this question, but is far more invasive than hormone supplementation in 
the males. Given the results of this study it is a logical follow-up experiment. 
The most obvious explanation for the results is that acute supplementation with 
estrogen and progesterone in male mice cannot replicate the influence of these hormones 
throughout the neural and physiologic development of the female mice. There is support 
for this finding in studies of the sexual dimorphism of the serotonin system, where early 
in rat development (day E14) estrogen has effects on neurite growth (115). Within the 
second postnatal week, there are already sex differences in the serotonergic system in 
rodent brains (116). Klink et al hypothesize that the difference in the dorsal raphe basal 
rate response to estrogen and progesterone is a gender-dependent trait, as the 
ovariectomized female mice do not take on the male phenotype (111). If the difference 
seen in the female and male Pet-1 knockout mice is due to this sort of gender-dependent 
developmental mechanism then no amount of hormone supplementation would be able to 
fully restore the male phenotype. 
In conclusion, the present study reports that male Pet-1 knockout mice have a 
variable ventilatory deficiency in response to a normoxic hypercapnic challenge, with a 
decreased HCVR at lower CCE exposures. This deficiency is partially reversed by 
supplementation with physiologic levels of female sex hormones, suggesting that the 
function of the remaining serotonergic neurons can be boosted by estrogen and 
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progesterone and providing a partial explanation for the sparing of the female Pet-1 
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